Evidence map›Paper›PMID 42763897›Full record

ReviewJournal of cellular biochemistry2026

SERPINE1 (PAI-1) Regulation in Mechanotransduction-Associated Cellular Senescence.

Intan Chairun Nisa, Pirawan Chantachotikul, Kei Takahata, Arif Nur Muhammad Ansori, Shinji Deguchi

Abstract readReview
In one paragraph

Review in Journal of cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Intan Chairun NisaDivision of Bioengineering, Graduate School of Engineering Science, University of Osaka, Toyonaka, Japan.
Pirawan ChantachotikulDivision of Bioengineering, Graduate School of Engineering Science, University of Osaka, Toyonaka, Japan.
Kei TakahataDivision of Bioengineering, Graduate School of Engineering Science, University of Osaka, Toyonaka, Japan.
Arif Nur Muhammad AnsoriPostgraduate School, Universitas Airlangga, Surabaya, Indonesia.ORCID https://orcid.org/0000-0002-1279-3904
Shinji DeguchiDivision of Bioengineering, Graduate School of Engineering Science, University of Osaka, Toyonaka, Japan.ORCID https://orcid.org/0000-0002-0556-4599

Funding

Japan Society for the Promotion of Science 23H04928
6 · The paper itself

Abstract

Cellular senescence is a complex biological process characterized by irreversible cell-cycle arrest and acquisition of the senescence-associated secretory phenotype (SASP). Beyond biochemical stress, increasing evidence indicates that mechanical cues from the extracellular microenvironment contribute to the regulation of senescence; however, the molecular mechanisms linking mechanotransduction to senescent phenotypes remain incompletely understood. SERPINE1 (plasminogen activator inhibitor-1, PAI-1) has emerged as a key mechanosensitive effector induced downstream of mechanotransduction signaling pathways. In this review, we discuss SERPINE1 as both a hallmark of cellular senescence and a functional mediator linking mechanotransduction to senescence-associated processes. Once induced, SERPINE1 contributes to cell-cycle arrest and extracellular matrix (ECM) remodeling by inhibiting plasmin-dependent proteolysis. The resulting ECM accumulation and matrix stiffening further enhance integrin-dependent mechanotransduction, promoting further SERPINE1 expression and establishing a self-reinforcing mechanobiological feedback loop. SERPINE1 also contributes to senescence-associated inflammatory signaling, which may further support the maintenance of the senescent phenotype. Together, these findings identify SERPINE1 as a mechanistic link between mechanotransduction, ECM remodeling, and cellular senescence. Pharmacological studies using PAI-1 inhibitors further support the biological importance of this pathway and suggest that SERPINE1 may represent a potential therapeutic target for senescence-associated fibrotic diseases.

Indexed as

Cellular SenescenceMechanotransduction, CellularPlasminogen Activator Inhibitor 1AnimalsExtracellular MatrixHumansSenescence-Associated Secretory PhenotypePlasminogen Activator Inhibitor 1SERPINE1 protein, humancellular senescenceextracellular matrixmechanotransductionPAI‐1SERPINE1

Identifiers

PMID42763897
PMCPMC13590038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.